| Mar'20 | Mar'19 | |||||
|---|---|---|---|---|---|---|
Operating activities | ||||||
Net loss | ||||||
0 | 0 | |||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Accretion of discount on marketable securities | ||||||
0 | 0 | |||||
Depreciation and amortization | ||||||
0 | 0 | |||||
Stock-based compensation expense | ||||||
0 | 0 | |||||
Gain on foreign currency translation | ||||||
0 | 0 | |||||
Noncash interest income (loss), net | ||||||
0 | 0 | |||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
0 | 0 | |||||
Prepaid expenses and other long-term assets | ||||||
0 | 0 | |||||
Accounts payable and accrued liabilities | ||||||
0 | 0 | |||||
Deferred revenue | ||||||
0 | 0 | |||||
Deferred rent | ||||||
0 | 0 | |||||
Net cash used in operating activities | ||||||
0 | 0 | |||||
Investing activities | ||||||
Purchase of marketable securities | ||||||
0 | 0 | |||||
Purchase of property and equipment | ||||||
0 | 0 | |||||
Net cash used in investing activities | ||||||
0 | 0 | |||||
Financing activities | ||||||
Proceeds from public offering, net of issuance costs | ||||||
0 | 0 | |||||
Proceeds from the sale of convertible preferred stock, net of issuance costs | ||||||
0 | 0 | |||||
Proceeds from issuance of common stock, net of repurchases | ||||||
0 | 0 | |||||
Net cash provided by financing activities | ||||||
0 | 0 | |||||
Net increase (decrease) in cash and cash equivalents | ||||||
0 | 0 | |||||